Open-label, add-on trial of cetirizine for neuromyelitis optica

OBJECTIVE: This pilot study preliminarily examined the efficacy and tolerability of cetirizine as an add-on to standard therapy for neuromyelitis optica (NMO). METHODS: Eligible participants met the Wingerchuk 2006 diagnostic criteria or had a single typical episode along with positive NMO immunoglo...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz Sand, Ilana, Fabian, Michelle T., Telford, Russell, Kraus, Thomas A., Chehade, Mirna, Masilamani, Madhan, Moran, Thomas, Farrell, Colleen, Ebel, Shelly, Cook, Lawrence J., Rose, John, Lublin, Fred D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201737/
https://www.ncbi.nlm.nih.gov/pubmed/30426035
http://dx.doi.org/10.1212/NXI.0000000000000441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201737/
https://www.ncbi.nlm.nih.gov/pubmed/30426035
http://dx.doi.org/10.1212/NXI.0000000000000441

Ejemplares similares